Physician profile
Leroy Fredericks
NPI 1043335755
$17,247.17
in general payments reported to CMS, 2019-2025
83 companies · $3,878 in 2025
The $3,878 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,423 · 2020: $787 · 2021: $1,437 · 2022: $2,820 · 2023: $2,932 · 2024: $2,970 · 2025: $3,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,472 · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,471.83 |
| Education | $307.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,203.09 | 2019-2025 | Calquence, Imfinzi, Enhertu |
| Novartis Pharmaceuticals Corporation | $1,025.10 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $960.41 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Amgen INC. | $929.64 | 2019-2025 | Kyprolis, Blincyto, Kyprolis |
| Pfizer INC. | $854.02 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $785.67 | 2019-2025 | Opdivo, Opdualag |
| Celgene Corporation | $669.59 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Daiichi Sankyo INC. | $654.77 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $634.47 | 2019-2025 | Ninlaro, Alunbrig, Fruzaqla |
| Astellas Pharma US INC | $573.87 | 2019-2025 | Vyloy, Xtandi, Padcev |
| Janssen Biotech, INC. | $571.10 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Eisai INC. | $552.48 | 2019-2025 | |
| Glaxosmithkline, LLC. | $552.17 | 2019-2025 | Ojjaara, Jemperli, Zejula |
| Genentech USA, INC. | $506.79 | 2019-2025 | Polivy, Columvi, Lunsumio |
| Genzyme Corporation | $425.15 | 2019-2025 |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $395.58 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Bayer Healthcare Pharmaceuticals INC. | $394.49 | 2019-2025 | |
| Sobi, INC | $335.64 | 2022-2025 | |
| Genmab U.S., INC. | $319.77 | 2022-2025 | Tivdak, Epkinly |
| Incyte Corporation | $289.72 | 2019-2025 | Jakafi, Pemazyre, Monjuvi |
| Beigene USA, INC. | $237.25 | 2020-2025 | Brukinsa, Tevimbra |
| Puma Biotechnology, INC. | $230.68 | 2019-2025 | |
| Taiho Oncology, INC. | $220.34 | 2022-2025 | |
| Abbvie INC. | $194.01 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $188.07 | 2019-2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $183.65 | 2019-2025 | Gilotrif |
| Gilead Sciences, INC. | $173.72 | 2021-2025 | Trodelvy |
| Adaptive Biotechnologies Corporation | $169.88 | 2023-2025 | Clonoseq |
| Ipsen Biopharmaceuticals, INC | $153.44 | 2019-2025 | Somatuline Depot, Onivyde, Tazverik |
| Jazz Pharmaceuticals INC. | $143.82 | 2021-2025 | |
| Exelixis INC. | $143.02 | 2019-2025 | Cabometyx |
| Stemline Therapeutics INC. | $139.65 | 2023-2025 | Orserdu |
| Aveo Pharmaceuticals, INC. | $138.35 | 2021-2025 | Fotivda |
| Mirati Therapeutics, INC. | $126.71 | 2023-2024 | Krazati |
| Emd Serono, INC. | $118.05 | 2019-2025 | Bavencio |
| Seagen INC. | $116.41 | 2021-2023 | Adcetris, Padcev, Tukysa |
| Alexion Pharmaceuticals, INC. | $108.45 | 2019-2023 | Ultomiris |
| Servier Pharmaceuticals LLC | $107.74 | 2023-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $101.16 | 2019-2022 | |
| Pharmacosmos Therapeutics INC. | $100.28 | 2021-2025 | Monoferric |
| Array Biopharma INC | $98.18 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Blueprint Medicines Corporation | $86.36 | 2020-2023 | Ayvakit |
| Kite Pharma, INC. | $80.52 | 2021-2023 | |
| Tesaro, INC. | $73.81 | 2019 | |
| Beone Medicines USA, INC. | $63.56 | 2025 | Brukinsa |
| Springworks Therapeutics, INC. | $56.93 | 2024-2025 | Ogsiveo |
| Pharmaessentia USA Corporation | $55.57 | 2025 | Besremi |
| Global Blood Therapeutics, INC. | $55.24 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $54.46 | 2023-2025 | Yonsa, Odomzo |
| Teva Pharmaceuticals USA, INC. | $53.17 | 2019-2021 | |
| Adc Therapeutics America, INC. | $53.09 | 2022-2025 | |
| Tersera Therapeutics LLC | $49.15 | 2021-2025 | Xermelo |
| Clovis Oncology, INC. | $48.15 | 2019-2020 | |
| Acrotech Biopharma INC. | $47.19 | 2025 | Beleodaq |
| Tempus Ai, INC | $44.23 | 2025 | Xt Cdx |
| Geron Corporation | $35.23 | 2025 | Rytelo |
| Dendreon Pharmaceuticals LLC | $33.97 | 2019 | |
| Foundation Medicine, INC. | $33.45 | 2022 | |
| Rigel Pharmaceuticals, INC. | $30.51 | 2022 | |
| Cti Biopharma Corp. | $30.37 | 2023 | Vonjo |
| Immunocore Limited | $28.47 | 2024-2025 | Kimmtrak |
| Kyowa Kirin, INC. | $27.59 | 2019-2020 | |
| Agios Pharmaceuticals, INC. | $27.54 | 2019-2025 | Pyrukynd |
| Sirtex Medical INC | $25.54 | 2023 | Sir-Spheres Microspheres |
| Catalyst Pharmaceuticals, INC. | $24.21 | 2024 | |
| Legend Biotech USA INC. | $24.12 | 2025 | Carvykti |
| Syndax Pharmaceuticals, INC. | $23.07 | 2025 | |
| Acceleron Pharma, INC. | $20.33 | 2021 | |
| Recordati_rare_diseases_inc. | $19.89 | 2025 | Sylvant |
| Akcea Therapeutics, INC. | $17.62 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.48 | 2025 | Adstiladrin |
| Karyopharm Therapeutics INC. | $17.45 | 2023 | Xpovio |
| G1 Therapeutics, INC. | $17.21 | 2023 | Cosela |
| Pharmaand Gmbh | $16.98 | 2025 | Rubraca |
| Myriad Genetic Laboratories, INC. | $16.03 | 2025 | Myrisk |
| Verastem, INC. | $15.84 | 2019 | |
| Dova Pharmaceuticals | $15.81 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $14.90 | 2019 | |
| Chiesi USA, INC. | $14.73 | 2022 | |
| Janssen Scientific Affairs, LLC | $14.38 | 2023 | Darzalex, Tecvayli |
| Partner Therapeutics, INC. | $13.23 | 2019 | |
| Coherus Oncology, INC. | $12.86 | 2022 | |
| Emmaus Medical, INC. | $10.55 | 2023 | Endari |
Drugs and devices associated with these payments
Keytruda $465Enhertu $442Reblozyl $355Opdivo $329Vitrakvi $279Stivarga $279Lenvima $263Calquence $258Lynparza $256Ninlaro $250Jaypirca $241Kisqali $238Darzalex $232Verzenio $216Doptelet $203Tecvayli $180Brukinsa $179Imfinzi $179Clonoseq $170Nubeqa $169Ojjaara $167Inqovi $165Lonsurf $165Xtandi $157Tivdak $154Retevmo $140Orserdu $140Elrexfio $137Adcetris $134Imbruvica $131Epkinly $130Krazati $127Polivy $125Scemblix $124Jakafi $123Bosulif $121Libtayo $121Elahere $120Opdualag $118Cabometyx $114Talzenna $111Talvey $110Tibsovo $108Welireg $106Onivyde $103Somatuline Depot $103Alunbrig $101Fotivda $98.92Mektovi $86.10Braftovi $86.10Datroway $85.48Lunsumio $83.37Columvi $83.37Fruzaqla $82.13Lorbrena $82.06Oxbryta $81.43Ibrance $80.06Vyloy $79.98Jemperli $78.65Zejula $78.65Itovebi $77.33Inlyta $75.01Enjaymo $71.40Gilotrif $69.89Fabhalta $61.10Piqray $60.42Sarclisa $58.87Ogsiveo $56.93Trodelvy $56.86Ziihera $55.88Besremi $55.57Padcev $54.97Besponsa $54.90Odomzo $54.46Yonsa $54.46Injectafer $54.02Tukysa $52.80Zepzelca $50.29Nerlynx $47.68Beleodaq $47.19Kyprolis $46.05Tasigna $44.85Xt Cdx $44.23Xalkori $43.72Tecentriq $41.45Phesgo $40.56Hyqvia $39.94Monoferric $37.53Rytelo $35.23Orgovyx $34.65Bavencio $32.60Xermelo $31.81Keytruda Qlex $30.70Vonjo $30.37Cablivi $30.06Pomalyst $29.03Kimmtrak $28.47Sir-Spheres Microspheres $25.54Idhifa $24.72Firdapse $24.21
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leroy Fredericks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.